Aurinia’s Dosing Patent For Lupkynis A ‘Slippery Slope’ To Extending US Market Exclusivity?

 
• By Cathy Kelly
  
Price Watchdog Wary Of New Ways To Extend Patent Life

More from Legal & IP

More from Pink Sheet